Remdesivir allowed in moderate cases

India’s drug regulator has allowed Mylan to expand the indication of remdesivir to “for moderate Covid-19 patients”

Teena Thacker
  • Updated On Oct 14, 2020 at 04:45 AM IST
Read by: 100 Industry Professionals
Reader Image Read by 100 Industry Professionals
NEW DELHI: India’s drug regulator has allowed Mylan to expand the indication of remdesivir to “for moderate Covid-19 patients” after the global drug major approached it with a proposal seeking the expansion. “After detailed deliberation the committee recommended for the grant of permission for expansion of the indication for moderate Covid-19 patients in addition to the already approved indication,” said the minutes of the subject expert committee meeting dated October 9. Currently, remdesivir is allowed for emergency/compassionate use in treating severely-ill Covid-19 patients.
  • Published On Oct 14, 2020 at 04:45 AM IST
Be the first one to comment.
Comment Now

Join the community of 2M+ industry professionals

Subscribe to our newsletter to get latest insights & analysis.

Download ETHealthworld App

  • Get Realtime updates
  • Save your favourite articles
Scan to download App